A review of the genomics of myasthenia gravis

Advanced age is associated with an increased response to autoantigens, although the implications of MG's age and sex-specic frequency distribution in pathogenesis remain unclear. In the last two decades, the trend has shown a progression in several MG patients, which urges the need to dene better prevention and treatment guidelines. Early diagnosis and risk factor screening play a key role in knowing more about MG's pathogenesis and therapeutic modalities. In this article we have reviewed the latest in the genomics of myasthenia gravis.